Why the study?
The 2023 ACC/AHA/ACCP/HRS guidelines introduced a paradigm shift in AF management, prompting a review to examine these guidelines and equip general internists to navigate the evolving care landscape.
The review highlights the 2023 ACC/AHA/ACCP/HRS guidelines' paradigm shift towards early detection, risk factor management, and multidisciplinary care in atrial fibrillation.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, impacting approximately 6.1 million adults in the United States, with projections to increase two-fold by 2030. AF significantly increases the risk of stroke and other adverse cardiovascular events, leading to increased morbidity and mortality. The 2023 ACC/AHA/ACCP/HRS guidelines present a paradigm shift in AF management, moving from a duration-based classification to a more comprehensive, patient-centered approach. This includes a novel AF classification system that emphasizes early detection and intervention, including risk factors and lifestyle modification tailored to each patient's risk profile. Moreover, the recommendations advocate for a multidisciplinary care model, ensuring coordinated management involving primary care providers and specialists. Primary care providers play a crucial role in initiating risk factor management and lifestyle interventions, even before the development of AF. This review aims to thoroughly examine the guidelines for the diagnosis and management of AF and equip general internists with the necessary insights to navigate the evolving landscape of AF care effectively.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2024) conducted a review in Atrial fibrillation. 2023 ACC/AHA/ACCP/HRS guidelines was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: